The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Regulatory News (IBT)

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 604.00
Bid: 602.00
Ask: 606.00
Change: -8.00 (-1.31%)
Spread: 4.00 (0.664%)
Open: 612.00
High: 616.00
Low: 602.00
Prev. Close: 612.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

5 Feb 2020 10:52

RNS Number : 0612C
Intl. Biotechnology Trust PLC
05 February 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

International Biotechnology Trust plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Charles Stanley Group plc

City and country of registered office (if applicable)

London, England

4. Full name of shareholder(s) (if different from 3.)v

Name

Charles Stanley & Co. Ltd.

Rock (Nominees) Ltd.

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

04/02/2020

6. Date on which issuer notified (DD/MM/YYYY):

05/02/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

4.89%

0%

4.89%

38,557,663

Position of previous notification (if

applicable)

5.06%

0%

5.06%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares Ord 5p

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0004559349

Nil

1,883,752

Nil

4.89%

SUBTOTAL 8. A

1,883,752

4.89%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Rock (Nominees) Ltd

Charles Stanley & Co. Ltd.

 

4.89%

0%

4.89%

Charles Stanley Group is the holding company of the above

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

London, England

Date of completion

05/02/2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUVSRRRKUURAR
Date   Source Headline
8th Nov 20224:41 pmRNSTransaction in Own Shares
7th Nov 20225:20 pmRNSTransaction in Own Shares
4th Nov 20224:40 pmRNSTransaction in Own Shares
3rd Nov 20224:57 pmRNSTransaction in Own Shares
1st Nov 20225:22 pmRNSTransaction in Own Shares
1st Nov 202211:26 amRNSTotal Voting Rights
1st Nov 20227:00 amRNSAnnual Financial Report
31st Oct 20225:20 pmRNSTransaction in Own Shares
27th Oct 20225:33 pmRNSTransaction in Own Shares
26th Oct 20224:39 pmRNSTransaction in Own Shares
25th Oct 20228:00 amRNSPortfolio Update
24th Oct 20225:12 pmRNSTransaction in Own Shares
18th Oct 20225:36 pmRNSTransaction in Own Shares
17th Oct 20221:16 pmRNSTransaction in Own Shares
13th Oct 20225:55 pmRNSTransaction in Own Shares
13th Oct 20227:00 amRNSKepler Trust Intelligence: New Research
3rd Oct 202212:07 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSCompliance with the Market Abuse Regulation
20th Sep 20225:22 pmRNSTransaction in Own Shares
20th Sep 20228:00 amRNSPortfolio Update
25th Aug 20228:30 amRNSPortfolio Update
1st Aug 202211:12 amRNSTotal Voting Rights
22nd Jul 20223:29 pmRNSDividend Declaration
20th Jul 20229:00 amRNSPortfolio Update
11th Jul 20221:26 pmRNSReplacement: Transaction in Own Shares
7th Jul 20225:45 pmRNSTransaction in Own Shares
6th Jul 20225:16 pmRNSTransaction in Own Shares
1st Jul 20225:40 pmRNSTransaction in Own Shares
1st Jul 20222:37 pmRNSBlock listing Interim Review
30th Jun 20227:15 amEQSHardman & Co Research: International Biotechnology Trust (IBT) - M&A activity on the rise
21st Jun 202210:30 amRNSPortfolio Update
1st Jun 202211:53 amPRNNet Asset Value(s)
1st Jun 202210:14 amRNSTotal Voting Rights
31st May 202210:53 amPRNNet Asset Value(s)
30th May 202211:35 amPRNNet Asset Value(s)
27th May 202210:46 amPRNNet Asset Value(s)
26th May 202210:05 amPRNNet Asset Value(s)
25th May 202211:31 amPRNNet Asset Value(s)
24th May 202210:24 amPRNNet Asset Value(s)
23rd May 202211:23 amPRNNet Asset Value(s)
18th May 20227:00 amRNSPortfolio Update
11th May 20226:09 pmRNSDirector/PDMR Shareholding
11th May 20224:47 pmRNSPortfolio Update
6th May 202211:00 amRNSCorrection: Half-year Report
4th May 20227:00 amRNSHalf-year Report
3rd May 20223:16 pmRNSTotal Voting Rights
21st Apr 20227:00 amRNSPortfolio Update
14th Apr 202210:30 amPRNNet Asset Value(s)
13th Apr 202211:18 amPRNNet Asset Value(s)
12th Apr 202210:43 amPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.